Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
September 19, 2024 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Thought Leadership & Innovation Foundation Proudly Accepts Ownership of Limb Loss and Preservation Registry in Collaboration with Amputee Coalition
September 18, 2024 13:38 ET
|
Thought Leadership & Innovation Foundation
McLEAN, Va., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Thought Leadership & Innovation Foundation (TLI), a not-for-profit organization that works at the nexus of science, technology and public health,...
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
September 05, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
Pacific Software Inc. Obtaining Quotes for the Manufacturing Cycle for Scientifically Tested Medical Food Cocktail Focused on Memory Health
June 28, 2024 18:43 ET
|
Pacific Software Inc.
Pacific Software Inc. expands into memory health with SuppleMEM AD™ and A.L.Z. Defense™. USA and Mexico distribution is planned for Q3 2024.
Pacific Software Inc. Acquires Scientifically Tested Medical Food Cocktail Focused on Memory Health
May 24, 2024 09:00 ET
|
Pacific Software Inc.
Pacific Software Inc. expands into brain health, acquiring proven SuppleMEM AD™ and A.L.Z. Defense™, backed by NIH research for strategic growth and profit
Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update
November 03, 2023 16:15 ET
|
Aridis Pharmaceuticals, Inc.
Received two grant awards from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health LOS GATOS, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) --...
Ocugen Mucosal Vaccine Candidate OCU500 Selected by NIH/NIAID Project NextGen for Inclusion in Clinical Trials
October 10, 2023 06:30 ET
|
Ocugen
NIAID is conducting early phase clinical trials on select next generation vaccine candidates with the intent to identify the most effective platforms and delivery routesOCU500 will be tested as both...
Neurostimulation Devices Market 2023 Report - Reach $11.82 Billion, Globally, by 2030 - Comprehensive Report by The Insight Partners
October 04, 2023 10:32 ET
|
The Insight Partners
Pune, India, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Neurostimulation devices attach electrodes to the brain, spinal cord, or peripheral nerves. Each device can collect and store data over time, and the...
60 Degrees Pharmaceuticals Study Results Published by New Microbes and New Infections Demonstrate Tafenoquine Exhibits Broad Spectrum Antifungal Activity
August 30, 2023 07:32 ET
|
Sixty Degrees Pharmaceuticals
Data showed tafenoquine does not exhibit cross-susceptibility with fluconazole against Candida spp.Effective treatment of drug-resistant Candida infections is an unmet need in U.S. marketPresumed mode...
BrainHQ selected for NIH-funded Study for Long Covid Cognitive Issues
August 02, 2023 08:00 ET
|
Posit Science
SAN FRANCISCO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- As announced by the US National Institutes of Health (NIH), BrainHQ is being incorporated into phase 2 clinical trials addressing persistent...